CKD Bio Corp. (KRX:063160)
South Korea · Delayed Price · Currency is KRW 13,600
+70 (0.52%)
Last updated: Aug 6, 2026, 2:25 PM KST
CKD Bio Market Cap
CKD Bio has a market cap or net worth of 74.23 billion as of August 5, 2026. Its market cap has decreased by -40.26% in one year.
Market Cap
74.23B
Enterprise Value
n/a
Revenue
159.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,600.00
ChartMarket Cap Chart
Since March 1, 2002, CKD Bio's market cap has increased from 10.15B to 74.23B, an increase of 631.55%. That is a compound annual growth rate of 8.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 74.23B | -33.51% |
| Dec 30, 2025 | 111.64B | -7.50% |
| Dec 30, 2024 | 120.69B | -7.76% |
| Dec 28, 2023 | 130.84B | 0.21% |
| Dec 29, 2022 | 130.57B | -43.06% |
| Dec 30, 2021 | 229.31B | -47.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyongbo Pharmaceutical | 122.40B |
| HANDOK | 117.57B |
| SAMSUNG PHARM. Co., LTD. | 117.18B |
| HLB Pharmaceutical | 116.27B |
| Jeil Pharma Holdings | 107.00B |
| CMG Pharmaceutical | 105.02B |
| Enzychem Lifesciences | 76.86B |
| Ildong Holdings | 69.56B |